Amgen Inc. (AMGN) News Headlines

▮ More

Date

Headline

5/22/2019 2:19:03 AM Amgen Offers To Buy Nuevolution For SEK 32.50/shr In Cash - Quick Facts

5/22/2019 2:02:31 AM Amgen Offers SEK 32.50 In Cash For Each Share In Nuevolution

5/2/2019 4:01:44 PM Amgen And Syapse Announce Precision Medicine Collaboration In Oncology

4/30/2019 4:26:43 PM Amgen Updates Earnings Guidance - Quick Facts

4/30/2019 4:08:13 PM Amgen Inc. (AMGN) Has Raised Its 2019 EPS Estimate To 13.25 - 14.30 From 13.10 - 14.30

4/30/2019 4:07:29 PM Amgen Inc. (AMGN) Has Raised Its 2019 Revenue Estimate To $22.0 - $22.9 Bln From $21.8 - $22.9 Bln

4/30/2019 4:04:44 PM Amgen Inc. Q1 adjusted earnings Beat Estimates

4/30/2019 4:02:34 PM Amgen Q1 Non-GAAP EPS Increase 3% To $3.56

4/30/2019 6:05:07 AM Amgen Q1 19 Earnings Conference Call At 5:00 PM ET

4/9/2019 6:27:18 PM FDA Approves Amgen's Osteoporosis Drug Evenity

4/7/2019 10:36:15 AM Amgen Presents New Data At WCO-IOF-ESCEO 2019 Revealing Osteoporosis Treatment Gap In Europe

4/4/2019 10:35:27 PM Novartis In Legal Dispute With Amgen On Migraine Drug Collaboration

3/25/2019 10:57:34 AM S&P 500 Q4 Share Repurchases Increases 62.8% T-o-y To $223.0 Bln

3/12/2019 9:31:38 AM Amgen Launches Cholesterol 911 National Initiative

3/7/2019 4:19:30 PM Amgen Declares Quarterly Dividend Of $1.45, Payable June 7/ Record May 17

3/7/2019 4:07:36 PM Amgen Inc. (AMGN) Declares $ 1.45 Dividend for Q2 19, Record Date 5/17/2019

2/25/2019 5:13:40 PM Amgen: Delaware Jury Upholds Validity Of Two Patents Related To PCSK9 Antibodies

2/25/2019 4:58:27 PM Amgen Says A Delaware Jury Delivered Verdict In Its Favor Upholding Validity Of Two Patents On PCSK9 Antibodies

2/21/2019 8:31:31 AM Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil

1/29/2019 4:04:22 PM Amgen Inc. Q4 adjusted earnings Beat Estimates